Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II. (Q41062569)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

A Jungwirth

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

G Halmos

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

K Groot

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

K Szepeshazi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

J Pinski

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

P Armatis

7

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

909-917

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Absence of HeLa cell contamination in 169 cell lines derived from human tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Epidermal growth factor and the kidney

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Synergistic effects of bombesin and epidermal growth factor on cancers

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C909%3A%3AAID-CNCR16%3E3.0.CO%3B2-4

21 January 2018

Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP

0 references

Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls

0 references

Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum

0 references

Identifiers

10.1002/(SICI)1097-0142(19980301)82:5<909::AID-CNCR16>3.0.CO;2-4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

release_airwrjfxefg2tapjoq444ta5gq

1 reference

https://api.fatcat.wiki/v0/release/airwrjfxefg2tapjoq444ta5gq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41062569&oldid=1839908625"